News

Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...
TikToker Symone Jade noticed a number of surprising side effects after she temporarily stopped taking Mounjaro.
The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.
LLY's oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.
Mounjaro users on Reddit are complaining of developing 'creepy' and 'saggy' skin on their necks after losing weight on GLP-1 ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...